Pradaxa Injury Lawsuits
Pradaxa (dabigatran) is a prescription blood-thinning medication approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AFib).
Unlike Coumadin® (warfarin), an anticoagulant drug approved more than 60 years ago, Pradaxa doesn’t require monthly blood testing and lacks strict dietary guidelines. Despite these benefits, data suggests that patients taking this drug may face an increased risk of severe bleeding requiring hospitalization or resulting in death.
If you or a loved one has taken Pradaxa and suffered from severe bleeding resulting in hospitalization, or if a loved one died from cerebral hemorrhage or other serious bleeding event, contact Ferrer, Poirot & Wansbrough. We’re dedicated to protecting victims’ rights against aggressive pharmaceutical giants, and our drug injury lawyers can help you—just call (800) 210-8503 or complete a free initial consultation form.
Serious Bleeding Events
Between March 2008 and October 2011, the drug’s manufacturer, Boehringer Ingelheim, reported 260 fatal bleeding events related to Pradaxa. Then, in December 2011, the FDA announced it was evaluating reports that serious bleeding is more common in patients using Pradaxa than in patients using other blood thinning drugs.
Patients at increased risk for abnormal bleeding while taking Pradaxa include those who:
- are 75 years old or older.
- have existing kidney problems.
- have stomach bleeding or an ulcer.
- are taking other drugs that can increase the risk of bleeding, including aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and other blood thinners.
If you’re taking Pradaxa, you shouldn’t stop taking the drug without first talking to your doctor, as this can increase the risk of stroke. It’s also important to notify healthcare professionals that you’re using Pradaxa before having any surgical or dental procedures.
Ferrer, Poirot & Wansbrough Attorneys Help Achieve $1.6 Million and $1.25 Million Pradaxa Awards
Alongside a team of trial attorneys from the law firms of Ury & Moskow and Childers, Schlueter & Smith, Yvette Ferrer of Ferrer, Poirot & Wansbrough helped recover more than $1.6 million in combined compensatory and punitive damages against Boehringer Ingelheim, the manufacturer of the blood-thinner Pradaxa, in a May 2019 verdict. The victim, a 75-year-old New York man, suffered a life-threatening upper gastrointestinal bleed while using Pradaxa.
The jury found that Boehringer Ingelheim Pharmaceuticals failed to properly disclose the risks associated with the medication. Additionally, the manufacturer was found liable for failing to inform doctors and patients of commercially available tests that identify whether patients’ blood levels indicate an unnecessarily elevated risk of bleeding.
In October 2018, a federal jury awarded $1.25 million to the family of an 84-year-old woman who died after taking Pradaxa. Attorneys Russ Abney, Hunter Linville, and Yvette Ferrer of Ferrer, Poirot & Wansbrough are proud to have served on the family’s legal team during this landmark case. The family was awarded $50,000 for their loved one’s medical expenses, $200,000 for pain and suffering, and an additional $1 million in punitive damages.
In May 2014, Boehringer Ingelheim agreed to pay $650 million to settle lawsuits filed on behalf of patients injured or killed by the drug. Evidence uncovered as part of victims’ Pradaxa lawsuits showed that the drug manufacturer failed to disclose data that suggested the risk of fatal bleeding among patients taking Pradaxa may be higher than was known when the drug was approved by U.S. regulators.
Pradaxa Side Effects
Pradaxa has a variety of side effects in addition to abnormal bleeding, including:
- Abdominal pain and discomfort
- Blood in urine or stools
- Coughing up blood or vomit that looks like coffee grounds
- Easy bruising
- Gastrointestinal ulcers
- Joint pain or swelling
- Pink or brown urine
Seek medical attention immediately if you experience any of these side effects as they could be signs of a serious drug injury.
FDA Finds Greater Pradaxa Gastrointestinal Bleeding Risk
In May 2014, the FDA published findings from a study that compared the health risks Pradaxa to the older blood-thinning drug Coumadin®.
After collecting data from more than 134,000 Medicare patients age 65 and older, researchers determined that patients taking Pradaxa faced a higher risk of gastrointestinal bleeding than patients taking warfarin.
Get Help With Your Pradaxa Lawsuit
At Ferrer, Poirot & Wansbrough, our Pradaxa injury lawyers are here to help if you’ve been hospitalized for severe bleeding, or if you’ve lost a loved one due to a bleeding event while taking Pradaxa. We’ve successfully defended the rights of thousands of clients, and we want to help you too. Contact our legal staff today—we’re available to take your call 24 hours a day, seven days a week.
Pradaxa® is a registered trademark of Boehringer Ingelheim GmbH.
This law firm is not associated with, sponsored by, or affiliated with Boehringer Ingelheim GmbH, Bloomberg LP, or the U.S. Food and Drug Administration.
Do not stop taking a prescription medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.
Cases may be referred to another attorney or law firm.